Skip to main content
Premium Trial:

Request an Annual Quote

Fluidigm Estimates Investment in Verinata at $3.1M After Illumina Acquisition

NEW YORK (GenomeWeb News) – Fluidigm disclosed in its Form 10-K this week that the fair value of its investment in Verinata Health is an estimated $3.1 million.

In its document filed with the US Securities and Exchange Commission, the South San Francisco, Calif.-based firm said it is a minority equity investor in Verinata, which was recently acquired by Illumina for $450 million. The carrying value — a measurement of an asset based on the company's balance sheet — of the investment, it added, was $1.3 million as of Dec. 31, 2012.

Under the terms of Illumina's acquisition of Verinata, it paid $350 million in cash. Based on that figure, Fluidigm estimated the fair value of its investment at $3.1 million as of Dec. 31, 2012.

Verinata is also eligible to receive milestone payments from Illumina of up to $100 million through 2015. Fluidigm said it did not factor these milestones into its fair value estimates because it is unable to assess the probability of such payments or when they would be made.

As a result, Fluidigm made a fair value estimate on its investment using Level 2 inputs, a method of evaluating a company's assets based on the degree of certainty around the asset's underlying value.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.